4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000921895-22-002055
Options or other derivatives
- Director acquired 12,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Ma-Weaver Jacob · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-06-15 | Grant or award : show line 1 in the form Stock Option (right to buy) | +12,000 | 12,000 | D |
Loading xslF345X03/form413392002_06212022.xml…